MyStartHealth Review 2026

What They Offer

MyStartHealth is a direct-to-consumer telehealth platform launched in 2022, offering compounded semaglutide and tirzepatide through a network the company describes as 600+ board-certified, U.S.-licensed doctors. The program is structured around periodic check-ins with clinical providers every 3–4 weeks, with unlimited access to the care team between appointments at no extra cost. MyStartHealth's price-lock guarantee — which holds the monthly rate steady even as doses escalate — is one of its clearest differentiators in a market where many providers charge more as dosages increase. MyStartHealth does not offer brand-name Wegovy or Ozempic; its own legal disclosures state this explicitly, and compounded medications are not FDA-approved as finished products.

Pricing & Plans

We could not verify a standalone consultation-only price on MyStartHealth's own site — its FAQ describes consultations as included in the plan price, so no separate $99 figure is published here.

What's Included

• Initial physician consultation and medical assessment
• GLP-1 medication (semaglutide or tirzepatide) shipped directly to home
• Provider check-ins every 3–4 weeks and dosage adjustments
• Unlimited messaging and 24/7 care team access, at no extra cost
• Free shipping on all orders
• Price-lock guarantee (rate never increases regardless of dose escalation)
• FSA/HSA payment options
• LegitScript certification (independently verifiable)

Eligibility

Is MyStartHealth Legit?

MyStartHealth carries an active LegitScript certification — verifiable directly through LegitScript's own certification lookup for mystarthealth.com — which is a meaningful, independently-audited credential for online pharmacy and telehealth compliance. It is not accredited by the Better Business Bureau.

It also has disclosed regulatory history. On September 9, 2025, the FDA issued MyStart Health LLC a warning letter (MARCS-CMS 714755) after reviewing the company's website. The letter found that the phrases "Generic Ozempic" and "Save with generics that offer the same active ingredients and results" — used to describe MyStartHealth's compounded semaglutide — were false or misleading under sections 502(a) and 502(bb) of the Federal Food, Drug and Cosmetic Act, because they implied the compounded product was equivalent to FDA-approved Ozempic when it is not FDA-approved. This is an advertising-language misbranding finding, not a claim about drug contamination, manufacturing safety, or patient harm — but it belongs in front of anyone deciding whether to use the service.

Guarantee & Refund Policy

Price-lock guarantee. MyStartHealth states on its own site that "the price of medication and ongoing care will never increase from your base plan amount, EVEN if your dosage increases in subsequent months (excluding our first-time discount)." This locks your monthly rate against dose-driven price increases; it does not lock in a promotional discount rate, and it is not a weight-loss or satisfaction guarantee.

Refunds. Per MyStartHealth's published refund policy, a full refund is issued only if a provider determines you are not eligible for a prescription, or if you cancel before your order is fulfilled. Once medication has shipped, the policy states no refund is issued under any circumstance — including if you change your mind, experience side effects, or decide not to continue treatment. There is no weight-loss-outcome refund guarantee published anywhere on MyStartHealth's site.

Clinical Results & Effectiveness

MyStartHealth has published minimal outcome data. The company reports outcomes based on a small, self-reported survey of only 16 customers, which is too limited to draw reliable conclusions. MyStartHealth lacks peer-reviewed clinical evidence or large-scale internal studies, making it harder to assess efficacy compared to competitors like MEDVi (100,000+ patient dataset) or Calibrate (peer-reviewed publication). Any published weight-loss percentages for FDA-approved drugs like Wegovy or Zepbound come from trials of those specific branded products — not the compounded semaglutide or tirzepatide MyStartHealth actually sells — so we have not repeated any such percentage as a MyStartHealth outcome on this page.

Customer Experience

We were unable to verify a specific review count or star rating for MyStartHealth at a primary source: Trustpilot blocked direct verification, and the figures reported by third-party aggregators were inconsistent with each other and with the "4.9 stars across 10,000 reviews" previously stated on this page. We have removed that figure rather than publish an unverified number. What we can confirm directly from MyStartHealth's own site: an active LegitScript certification, a stated price-lock guarantee, and a refund policy that pays out only before medication ships.

Frequently Asked Questions

Our Verdict

MyStartHealth is a reasonable pick for price-sensitive patients who want simple, flat-rate compounded GLP-1 pricing and don't need brand-name medication. The price-lock guarantee is real and independently confirmed, the LegitScript certification is verifiable, and the all-in pricing is genuinely transparent.

Two things hold the score at 6.5. The FDA's September 2025 warning letter over advertising language — while about marketing claims rather than drug safety — is exactly the kind of disclosure a reader deciding on a medication provider deserves to see. And the company publishes very little else that can be independently verified: no state-availability list, no reliable review data, and outcomes data from only 16 self-reporting customers. Choose it if flat-rate compounded pricing and a locked rate matter most to you. Look elsewhere if you want FDA-approved brand-name medication, a documented weight-loss guarantee, or a provider with a larger published evidence base.

We may earn a commission if you sign up through our links. It never changes our rankings.